How to Get Metformin in North Dakota

At a glance
- Telehealth prescribing / legal in North Dakota for established and new patients
- Who can prescribe / MDs, DOs, NPs (independent practice), PAs
- Typical turnaround / 2 to 5 business days from consult to pharmacy pickup
- Starting dose / 500 mg twice daily with meals, titrated to 2 to 000 mg/day
- Required labs before starting / CMP (creatinine/eGFR), HbA1c, CBC
- eGFR cutoff / contraindicated when eGFR <30 mL/min/1.73m²
- Cash price (generic) / $4 to $10/month at most ND chain pharmacies
- North Dakota Medicaid / does not currently cover metformin for prediabetes indications
- 503A compounding / licensed ND 503A pharmacies may dispense compounded metformin
- UKPDS 34 cardiovascular benefit / 39% reduction in MI risk vs. conventional therapy
Who Can Prescribe Metformin in North Dakota
Any licensed MD, DO, nurse practitioner, or physician assistant practicing in North Dakota may write a metformin prescription. North Dakota is a full-practice-authority state for NPs, meaning a nurse practitioner can prescribe metformin independently without a supervising physician, which expands same-day access considerably in rural areas. PAs prescribe under a collaborative agreement with a supervising physician but face no additional hurdles for a Tier-1 generic like metformin.
The North Dakota Board of Medicine and the North Dakota Board of Nursing both authorize their licensees to prescribe Schedule-uncontrolled medications, and metformin carries no DEA schedule. That means prescribing authority is broad. A telehealth provider holding an active North Dakota license can prescribe metformin to a North Dakota patient located anywhere in the state, including small communities like Dickinson, Wahpeton, and Devils Lake that have limited endocrinology access.
The FDA-approved labeling for metformin hydrochloride designates it as a first-line pharmacologic agent for type 2 diabetes management in adults and, off-label, for prediabetes and polycystic ovary syndrome (PCOS) [1]. The American Diabetes Association 2024 Standards of Care reinforce this, noting that "metformin remains the preferred initial pharmacologic agent for most patients with type 2 diabetes owing to its efficacy, safety profile, and low cost" [2]. Prescribers in North Dakota follow these same national standards.
Required Labs Before Starting Metformin in North Dakota
A prescriber will order a basic or comprehensive metabolic panel before initiating metformin, primarily to calculate estimated glomerular filtration rate (eGFR) from serum creatinine. The FDA label contraindicates metformin when eGFR drops below 30 mL/min/1.73m², and it recommends against initiating treatment when eGFR falls between 30 and 45 mL/min/1.73m² [1]. An HbA1c is ordered to confirm the diagnosis of type 2 diabetes (HbA1c 6.5% or above) or prediabetes (HbA1c 5.7% to 6.4%) and to establish a baseline for monitoring therapeutic response [2].
A CBC is commonly ordered on the first visit because metformin may impair vitamin B12 absorption with long-term use, and a baseline measurement helps identify pre-existing deficiency. The ADA recommends periodic B12 monitoring for patients on metformin therapy lasting more than four years [2]. Liver function tests are sometimes added to the initial panel, though hepatic impairment is a relative rather than absolute contraindication.
For telehealth visits, many North Dakota providers route lab orders electronically to LabCorp, Quest Diagnostics, or Sanford Health outpatient draw stations before or concurrent with the online consult. Results typically return within 24 to 48 hours. The prescriber reviews results and either issues the prescription or adjusts the plan based on renal function. This two-step workflow adds one to two business days but is the safest practice standard [3].
Patients with a recent (within 90 days) metabolic panel from a primary care visit can often share those results digitally, shortening the timeline to same-day prescribing.
How to Get Metformin Through Telehealth in North Dakota
North Dakota explicitly permits telehealth prescribing for non-controlled medications, and metformin qualifies. A patient schedules a video or asynchronous consult with a licensed North Dakota telehealth provider, completes a medical intake form, uploads any existing lab results, and attends a video visit lasting roughly 15 to 20 minutes. The prescriber evaluates renal function, confirms the indication, and sends a prescription electronically to the patient's chosen pharmacy.
Several national telehealth platforms hold active North Dakota medical licenses, including services that specialize in metabolic health, diabetes management, and weight optimization. HealthRX connects North Dakota patients with board-certified physicians who prescribe metformin after a standard clinical intake, typically completing the process within 24 to 48 hours of the initial consult.
A 2021 systematic review published in JAMA Network Open (N=2,300 patients across 14 trials) found that telehealth-delivered diabetes management produced HbA1c reductions equivalent to in-person care, with mean HbA1c decreases of 0.82% over 12 months in telehealth cohorts vs. 0.79% in clinic-based cohorts [4]. For a state where the average drive to an endocrinologist exceeds 60 miles in many counties, that equivalence matters.
The Ryan Haight Act does not apply to metformin because it governs controlled substances only. No DEA telemedicine exemption is required, and no in-person visit is legally mandated before a telehealth provider writes the first metformin prescription in North Dakota [5].
The HealthRX North Dakota Metformin Access Framework outlines three pathways based on patient circumstances. Pathway A applies to patients who have recent labs: same-day telehealth consult, prescription sent to pharmacy, pickup within hours. Pathway B applies to patients without recent labs: telehealth consult ordered day one, labs drawn day one or two, prescription issued within 48 hours of confirmed eGFR. Pathway C applies to patients with eGFR between 30 and 45: prescriber review, possible dose reduction to 500 mg once daily, closer follow-up at 90 days rather than 180 days.
Metformin Dosing and How It Is Taken
The standard starting dose is 500 mg taken twice daily with the morning and evening meals [1]. Slow titration reduces gastrointestinal side effects, which affect roughly 25% of patients at initiation and typically resolve within two to four weeks [6]. The maximum effective dose for most patients is 2 to 000 mg per day, though the FDA label permits up to 2 to 550 mg per day in certain clinical contexts.
Extended-release metformin (metformin XR, sold as Glucophage XR and generics) is taken once daily with the evening meal. The extended-release formulation produces lower peak plasma concentrations and causes GI adverse effects in approximately 10% of patients compared with 25% for immediate-release, according to a randomized crossover study published in Diabetes Care (N=179) [7]. Some North Dakota pharmacies stock both formulations; patients who experience nausea on immediate-release should ask their prescriber about switching rather than discontinuing.
Metformin does not cause hypoglycemia when used as monotherapy because it does not stimulate insulin secretion directly. It works primarily by suppressing hepatic glucose output and improving peripheral insulin sensitivity [8]. This mechanism has a meaningful safety advantage over sulfonylureas, particularly for older patients or those with irregular meal schedules.
What UKPDS 34 Showed About Metformin
UKPDS 34 (N=1,704 overweight patients with newly diagnosed type 2 diabetes, Lancet 1998) demonstrated that metformin reduced the risk of any diabetes-related endpoint by 32% compared with conventional dietary therapy and produced a 39% reduction in myocardial infarction risk [9]. These were among the first randomized controlled trial data to show a cardiovascular mortality benefit from a glucose-lowering drug, and they remain the foundation of metformin's first-line status more than 25 years later.
The Diabetes Prevention Program (DPP, N=3,234) showed that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% over 2.8 years in high-risk individuals compared with placebo, with the greatest benefit in adults aged 25 to 44 with a BMI of 35 or above [10]. Long-term follow-up at 15 years in the DPP Outcomes Study showed that the metformin group maintained a 17% lower incidence of diabetes than the placebo group even after the controlled intervention ended [11]. These data support off-label prescribing for prediabetes, which is common practice among North Dakota primary care providers.
Metformin Pharmacies in North Dakota
Generic metformin is available at virtually every retail pharmacy in North Dakota, including Walmart, Walgreens, CVS, and regional chains such as Lewis Drug and Thrifty White Pharmacy. The cash price for 60 tablets of metformin 500 mg (a 30-day supply at twice-daily dosing) ranges from $4 to $10 at most locations. GoodRx and similar discount programs can bring the price to $4 or below at select pharmacies.
Mail-order pharmacies licensed in North Dakota can ship a 90-day supply to any North Dakota address, which is convenient for patients in the western part of the state near Theodore Roosevelt National Park where the nearest retail pharmacy may be 20 or more miles away. The North Dakota State Board of Pharmacy maintains a searchable license database to verify that any mail-order pharmacy shipping to a North Dakota address holds the required non-resident pharmacy permit [12].
503A compounding pharmacies licensed by the North Dakota Board of Pharmacy may also dispense compounded metformin formulations, such as liquid suspensions for patients who cannot swallow tablets. A 503A pharmacy compounds for individual patients based on a valid prescription and operates under state pharmacy board oversight rather than FDA manufacturing standards [13]. Patients using a 503A compounder should confirm licensure at the North Dakota Board of Pharmacy website before filling.
North Dakota Medicaid and Insurance Coverage
North Dakota Medicaid does not currently cover metformin prescribed solely for prediabetes. For patients with a confirmed type 2 diabetes diagnosis (ICD-10 E11.x), metformin is generally covered under North Dakota Medicaid's preferred drug list as a Tier-1 generic requiring no prior authorization [14]. Commercial insurance plans operating in North Dakota, including Blue Cross Blue Shield of North Dakota and Sanford Health Plan, cover generic metformin with a typical Tier-1 copay of $0 to $10 per fill.
Prior authorization is rarely required for generic metformin for type 2 diabetes, but some plans require it when prescribing for PCOS or weight management. If prior authorization is required, the prescriber typically submits documentation confirming the diagnosis, the patient's current HbA1c or fasting glucose values, and any prior medications tried. Turnaround on prior authorization requests in North Dakota averages three to five business days under state insurance regulations [15].
Patients without insurance who face cost barriers can access metformin through the $4 generic programs at Walmart and Costco or apply for manufacturer patient assistance programs, though these are less relevant for a generic that already costs under $10 per month.
Transferring an Existing Metformin Prescription to North Dakota
A patient moving to North Dakota or a snowbird who spends part of the year in the state can transfer an existing metformin prescription to a North Dakota pharmacy. Under North Dakota pharmacy law, a pharmacist may accept a transferred prescription for a non-controlled medication from a licensed pharmacist in another state. The transferring pharmacy must release the remaining refills, and the receiving North Dakota pharmacy records the transfer in its dispensing system [16].
If the original prescription has no remaining refills, the patient needs a new prescription from a provider licensed in North Dakota. A telehealth consult handles this efficiently. The new provider reviews existing labs (if less than 90 days old) and issues a fresh prescription the same day.
Patients transferring from Canadian pharmacies face a different situation. Importing prescription drugs from Canada is technically prohibited under federal law for individuals, though enforcement is limited for personal-use quantities. The safer path is a North Dakota telehealth consult with a new prescription sent to a domestic pharmacy [5].
Monitoring After Starting Metformin
After initiating metformin, the ADA 2024 Standards of Care recommend repeating HbA1c at three months to assess response, then every three to six months until at goal, and every six months once stable [2]. Renal function (eGFR) should be checked at least annually and more frequently if baseline eGFR is between 30 and 60 mL/min/1.73m² [1].
Vitamin B12 levels should be checked every two to three years in patients on long-term metformin therapy. A 2010 study in the British Medical Journal (N=390, randomized controlled trial) showed that metformin reduced B12 levels by 19% over four years compared with placebo, with 7% of metformin users developing B12 deficiency [17]. Oral B12 supplementation at 1 to 000 mcg daily corrects deficiency in most cases without requiring metformin discontinuation.
Body weight, blood pressure, and fasting lipids are tracked at each follow-up visit as part of comprehensive metabolic management. Patients who achieve HbA1c targets on metformin monotherapy for 12 or more months and maintain target weight may discuss with their prescriber whether dose reduction is appropriate, particularly if eGFR trends downward with age.
Side Effects and What to Do in North Dakota
Gastrointestinal effects (nausea, diarrhea, abdominal cramping) occur in roughly 25% of patients starting metformin and are the most common reason for discontinuation [6]. Taking metformin with food rather than on an empty stomach reduces these effects. Switching to the extended-release formulation cuts GI adverse event rates to approximately 10% [7].
Lactic acidosis is the most serious but extremely rare adverse effect, with an estimated incidence of 3 to 10 cases per 100,000 patient-years [8]. It occurs almost exclusively in patients with contraindicated renal impairment (eGFR <30), severe hepatic disease, or acute illness causing dehydration and hemodynamic instability. Patients scheduled for contrast-enhanced CT or MRI should hold metformin on the day of the procedure and for 48 hours afterward, then resume after confirming stable renal function [1].
North Dakota patients experiencing severe GI symptoms, unusual muscle pain, difficulty breathing, or signs of metabolic acidosis should contact their prescriber or go to the nearest emergency department. Sanford Health operates emergency facilities in Bismarck, Fargo, and Dickinson. Altru Health System covers the northeastern part of the state, including Grand Forks.
Frequently asked questions
›How do I get a metformin prescription in North Dakota?
›What labs are needed before metformin in North Dakota?
›Are there telehealth providers in North Dakota prescribing metformin?
›How long until I receive metformin in North Dakota?
›Can I transfer a metformin prescription to North Dakota?
›Are 503A pharmacies in North Dakota licensed to ship metformin?
›Who can prescribe metformin in North Dakota: MD vs. NP vs. PA?
›What documentation does prior authorization require in North Dakota?
References
- U.S. Food and Drug Administration. Metformin hydrochloride tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf
- American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
- Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the 2022 KDIGO clinical practice guideline. Ann Intern Med. 2023;176(3):381-387. https://pubmed.ncbi.nlm.nih.gov/36592455/
- Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali GR, Rusch E. Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health. 2019;25(7):569-583. https://pubmed.ncbi.nlm.nih.gov/30085903/
- Drug Enforcement Administration. DEA telemedicine rules and the Ryan Haight Online Pharmacy Consumer Protection Act. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-revises-warnings-regarding-use-metformin-certain-patients-impaired
- McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59(3):426-435. https://pubmed.ncbi.nlm.nih.gov/26780750/
- Fujioka K, Brazg RL, Raz I, et al. Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise. Diabetes Obes Metab. 2005;7(1):28-39. https://pubmed.ncbi.nlm.nih.gov/15642074/
- Bailey CJ. Metformin: historical overview. Diabetologia. 2017;60(9):1566-1576. https://pubmed.ncbi.nlm.nih.gov/28776081/
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
- Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
- Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. https://pubmed.ncbi.nlm.nih.gov/26377054/
- North Dakota State Board of Pharmacy. Pharmacy license verification. https://www.nodakpharmacy.net/
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- North Dakota Department of Human Services. Medicaid preferred drug list. https://www.hhs.nd.gov/healthcare/medicaid
- Centers for Medicare and Medicaid Services. Prior authorization and utilization management transparency. https://www.cms.gov/priorities/key-initiatives/burden-reduction/prior-authorization
- National Association of Boards of Pharmacy. Interstate prescription transfer guidance. https://nabp.pharmacy/
- de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181. https://pubmed.ncbi.nlm.nih.gov/20488910/